Document is current
Any future updates will be listed below
-
Authors
Cao, Jianjun https://orcid.org/0000-0001-9160-0228
Belousoff, Matthew J. https://orcid.org/0000-0002-3229-474X
Johnson, Rachel M.
Keov, Peter https://orcid.org/0000-0002-3829-6455
Mariam, Zamara
Deganutti, Giuseppe https://orcid.org/0000-0001-8780-2986
Christopoulos, George https://orcid.org/0009-0002-9357-331X
Hick, Caroline A. https://orcid.org/0009-0007-8511-868X
Reedtz-Runge, Steffen https://orcid.org/0000-0002-9216-3311
Glendorf, Tine https://orcid.org/0000-0002-6874-7405
Ballarín-González, Borja https://orcid.org/0009-0008-4828-6374
Raun, Kirsten https://orcid.org/0000-0001-7605-8215
Bayly-Jones, Charles https://orcid.org/0000-0002-7573-7715
Wootten, Denise https://orcid.org/0000-0003-4563-1642
Sexton, Patrick M. https://orcid.org/0000-0001-8902-2473
-
Funding
Funding for this research was provided by:
Department of Health | National Health and Medical Research Council (1154434, 2025694, 1155302, 2026300)
Department of Education and Training | Australian Research Council (IC200100052, DP210101504, IC200100052)
- License Information
-
More Information
Article History
Received: 28 June 2024
Accepted: 28 March 2025
First Online: 10 April 2025
Competing interests
: P.M.S. is a co-founder and P.M.S. and D.W. are shareholders of Septerna Inc. P.M.S. and D.W. are co-founders and shareholders of Dacra Tx. T.G., K.R., B.B.-G., and S.R.-R. are employees and shareholders of Novo Nordisk. The work was funded, in part, by Novo Nordisk. All other authors declare no competing interests.
